EE48 Can We Afford to Overlook the Cost of Avoidable Complications in Type 2 Diabetes: A Health Economic Analysis to Evaluate What Is the ‘Cost of Not’ Acting in Turkey?
| Autor: | Deyneli, O, Solorzano, J, Mihajlović, J, Dinc, M, Erdogan, A |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S62-S62 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect